Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-month ART dispensing in adherence clubs
PACTR201810631281009Completed
- Sponsor
- Doctors Without Borders
- Start
- Oct 2017
- Countries
- 1
01
Overview
Randomised, open-label trial in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Doctors Without Borders. Primary endpoint: Retention and viral suppression over 24 months. Started Oct 2017; status: completed.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201810631281009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201810631281009.